Kevin Madagan

Practice Areas

Kevin is a healthcare and FDA regulatory attorney who focuses on issues related to the manufacturing, distribution, and sale of drugs (Rx, OTC, homeopathic), biologics, devices (Rx and OTC), combination products, and dietary supplements. His diverse clientele includes suppliers, manufacturers, repackagers, wholesale and private label distributors, clinical laboratories, third-party logistics providers (3PLs), carriers, pharmacies (503A, 503B, nuclear and radiopharmacy operations), and healthcare providers.

Kevin frequently advises strategic owners, private equity funds, underwriters, and other public and privately-held businesses on FDA and health care matters related to health care financing and securities transactions, as well as domestic and international mergers and acquisitions. His expertise includes providing legal and strategic guidance on supply chain logistics, commercialization activities, and health care compliance and enforcement.

Kevin previously served on the Editorial Advisory Board of Thompson’s FDA Advertising and Promotion Manual and has participated on numerous committees for the Food and Drug Law Institute (FDLI), including the Medical Device Committee. Additionally, he is a long-standing member of the planning committee for the Drug Information Association’s (DIA’s) annual Advertising and Promotion Regulatory Affairs Conference.

Kevin is also a founding member of the Young Lawyers Committee for the Lawyer’s Committee on Civil Rights.